Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HRT management: the American experience

B R Carr1

  • 1Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center at Dallas 75235-9032, USA.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.

Human reproduction open·2019
Same author

Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.

Human reproduction (Oxford, England)·2019
Same author

The human placenta expresses CYP17 and generates androgens de novo.

The Journal of clinical endocrinology and metabolism·2011
Same author

Inhibition of Src tyrosine kinase stimulates adrenal androgen production.

Journal of molecular endocrinology·2003
Same author

Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes.

The Journal of endocrinology·2002
Same author

Gene profiling of human fetal and adult adrenals.

The Journal of endocrinology·2001

Despite increased awareness, hormone replacement therapy (HRT) use in US postmenopausal women is lower than expected. Fear of cancer and side effects like bleeding deter many women from HRT.

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology
  • Public Health

Background:

  • Hormone replacement therapy (HRT) is used to manage menopausal symptoms.
  • Understanding HRT trends is crucial for women's health.
  • Historical and current practices influence patient outcomes.

Purpose of the Study:

  • To review the history of HRT in the US.
  • To analyze current clinical practices and prescription patterns.
  • To examine sales data for HRT products.

Main Methods:

  • Literature review to gather historical data.
  • Survey data collection on patient information sources and preferences.
  • Analysis of prescription and sales data for HRT in the US.

Related Experiment Videos

Main Results:

  • HRT use is highest in women aged 40-60 (35%) and declines with age.
  • Media and physicians are primary information sources for HRT.
  • Oral estrogens, particularly conjugated equine estrogens, dominate the market (86% of prescriptions).
  • Combined continuous or cyclic estrogen and progestogen regimens are common for women with a uterus.

Conclusions:

  • Despite increased awareness, HRT utilization remains lower than anticipated.
  • Fear of cancer and side effects like bleeding are significant barriers to HRT adoption.
  • Physicians' prescribing habits are evolving, with a trend towards broader practitioner involvement.
  • Transdermal estrogens are preferred for early postmenopausal women or those with early menopause.